01 15LXO IRELAND
02 18OMNIVIUM PHARMS
01 79867815
02 410016407
03 410149843
04 210231961
05 210413505
06 210420760
07 210857095
08 210894012
09 310933060
10 210973811
11 110987347
12 211040032
01 33Blank
01 4Y
02 29Blank
01 332037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10973811
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-3680
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10894012
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-3014
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10857095
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-3014
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10420760
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2478
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10413505
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-3014
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10149843
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2478
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10149843
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2479
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2225
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2226
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
Patent Expiration Date : 2037-02-07
US Patent Number : 10016407
Drug Substance Claim :
Drug Product Claim :
Application Number : 209575
Patent Use Code : U-2329
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-02-07
